Hypochlorous Acid (HOCl) as a Promising Respiratory Antiseptic

Area of Science:

• Medical Research
• Infectious Diseases
• Biochemistry

Background:

• The COVID-19 pandemic highlighted the need for effective global health interventions.
• Investigating new therapeutic mechanisms is complex, time-consuming, and costly.
• Antiseptic treatments offer a cost-effective and accessible approach to infection control.

Purpose of the Study:

• To explore the potential of hypochlorous acid (HOCl) as an in vivo antiseptic for respiratory tract infections.
• To assess HOCl's suitability for therapeutic inhalation against various pathogens.
• To discuss the mechanisms and efficacy of HOCl in combating respiratory illnesses.

Main Methods:

• Literature review of existing research on hypochlorous acid (HOCl).
• Analysis of HOCl's properties, including its natural occurrence, biocidal activity, and cytotoxicity.
• Examination of HOCl's historical medical applications, particularly in wound care.
• Evaluation of potential efficacy against respiratory pathogens like SARS-CoV-2, influenza, and RSV.

Main Results:

• Hypochlorous acid (HOCl) is a naturally occurring component of the innate immune system.
• HOCl exhibits broad-spectrum antimicrobial activity with low cytotoxicity.
• Previous medical use in wound treatment demonstrates HOCl's safety and efficacy.
• HOCl's properties suggest potential for treating respiratory mucosa infections.

Conclusions:

• Hypochlorous acid (HOCl) presents a promising, accessible therapeutic option for respiratory infections.
• Therapeutic inhalation of HOCl could be a viable strategy against bacterial and viral respiratory pathogens.
• Further research into HOCl for respiratory applications is warranted given its favorable profile.